What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Ambulatory Blood Pressure Monitoring

William White

Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

Michael Gallagher

AHA 2022: Chlorthalidone Compared to Hydrochlorothiazide for the Pre…

AHA 2022 Conference Coverage

A. Ishani

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

MUSC Cardiology

R. Mentz

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

MAFLD: What Is It?

Houston Methodist

D. Victor

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer…

Ken Fujioka

Neurovascular Mechanisms in Female Sexual Arousal Disorders and Pote…

"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.

N. Kim

2020 High Blood Pressure Guidelines: When Is BP Too High?

Houston Methodist DeBakey Heart and Vascular Center

A. Marie Navar

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Northwestern Medicine: The Connection Between Diabetes and Heart Dis…

Northwestern Medicine Bluhm Cardiovascular Institute

S. Shah, R. Kushner